Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Marchou

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Therapie|September 1, 1990
[Evaluation of the pharmacovigilance follow-up of zidovudine]S Gimenez, H Bagheri, B Marchou, et al.
AIDS (London, England)|May 1, 1994
Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBVP Brousset, E Drouet, D Schlaifer, et al.
Medecine Et Maladies Infectieuses|July 14, 2007
[Impact of HIV infection on malaria in adults]G Martin-Blondel, M Barry, L Porte, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 24, 2012
Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infectionF Nicot, A Saliou, S Raymond, et al.
Journal of Medical Virology|January 19, 1999
Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutationsJ Izopet, L Sailler, K Sandres, et al.
HIV Medicine|March 23, 2012
Factors associated with a strictly undetectable viral load in HIV-1-infected patientsG Martin-Blondel, K Sauné, V Vu Hai, et al.
Infection|May 28, 2013
FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasisP G Kyrtatos, A Debard, G Martin-Blondel, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 25, 2007
Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controlsC Delpierre, E Bonnet, F Marion-Latard, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 28, 2014
Minority resistant HIV-1 variants and the response to first-line NNRTI therapyF Nicot, K Sauné, S Raymond, et al.
AIDS (London, England)|November 23, 2000
Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimenJ Izopet, P Massip, C Souyris, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Therapie|September 1, 1990
[Evaluation of the pharmacovigilance follow-up of zidovudine]S Gimenez, H Bagheri, B Marchou, et al.
AIDS (London, England)|May 1, 1994
Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBVP Brousset, E Drouet, D Schlaifer, et al.
Medecine Et Maladies Infectieuses|July 14, 2007
[Impact of HIV infection on malaria in adults]G Martin-Blondel, M Barry, L Porte, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 24, 2012
Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infectionF Nicot, A Saliou, S Raymond, et al.
Journal of Medical Virology|January 19, 1999
Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutationsJ Izopet, L Sailler, K Sandres, et al.
HIV Medicine|March 23, 2012
Factors associated with a strictly undetectable viral load in HIV-1-infected patientsG Martin-Blondel, K Sauné, V Vu Hai, et al.
Infection|May 28, 2013
FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasisP G Kyrtatos, A Debard, G Martin-Blondel, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 25, 2007
Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controlsC Delpierre, E Bonnet, F Marion-Latard, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 28, 2014
Minority resistant HIV-1 variants and the response to first-line NNRTI therapyF Nicot, K Sauné, S Raymond, et al.
AIDS (London, England)|November 23, 2000
Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimenJ Izopet, P Massip, C Souyris, et al.
Pageof 8